1035343-44-2

Upstream product

• 1973-04-2 2,4-dichloro-6-methyl-1,3,5-triazine 
• 302964-24-5 2-amino-N-(2-chloro-6-methylphenyl)-1.3-thiazole-5-carboxamide 
• 863127-76-8 (E)-N-(2-chloro-6-methylphenyl)-3-ethoxyacrylamide 

Downstream Products

• 1035343-45-3 C₂₁H₂₅ClN₈O₂S 
• 1258411-09-4 C₂₄H₂₄ClN₉OS 
• 1258411-07-2 C₁₉H₂₁ClN₈OS 
• 1258411-08-3 C₂₂H₂₄ClN₉OS 
• 1258411-10-7 C₂₃H₂₃ClN₁₀OS 
• 1258411-04-9 C₂₅H₃₂ClN₉O₂S 
• 1258411-05-0 C₂₅H₂₆ClN₉OS 
• 1035343-57-7 C₂₁H₂₄ClN₇O₂S 
• 1035343-58-8 C₂₁H₂₂ClN₉OS 
• 1035343-47-5 C₂₀H₂₃ClN₈OS 
• 1258411-11-8 C₂₅H₂₅ClN₈OS 
• 1258411-12-9 C₂₆H₂₄ClF₃N₈OS 

Relevant academic research and scientific papers

TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS

The present invention comprises inter alia compounds as shown in formula (I) or a pharmaceutically acceptable salt thereof.

TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS

The invention provides for Triazine derivatives and their use to modulate protein kinase activity in a variety of conditions and diseases.